299 related articles for article (PubMed ID: 19624871)
1. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
Jian J; Hu ZF; Huang Y
Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
[TBL] [Abstract][Full Text] [Related]
2. [Inducement effect of ginsenoside Rg3 on apoptosis of human bladder transitional cell carcinoma cell line EJ].
Chen JX; Peng HM; Pu SP; Guo YP
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1680-4. PubMed ID: 18027667
[TBL] [Abstract][Full Text] [Related]
3. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
6. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL.
Macdonald A; Campbell DG; Toth R; McLauchlan H; Hastie CJ; Arthur JS
BMC Cell Biol; 2006 Jan; 7():1. PubMed ID: 16403219
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
Luo Y; Zhang P; Zeng HQ; Lou SF; Wang DX
Mol Med Rep; 2015 Sep; 12(3):3557-3562. PubMed ID: 25998024
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.
Popivanova BK; Li YY; Zheng H; Omura K; Fujii C; Tsuneyama K; Mukaida N
Cancer Sci; 2007 Mar; 98(3):321-8. PubMed ID: 17270021
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells.
Zhang YH; Li HD; Li B; Jiang SD; Jiang LS
Oncol Rep; 2014 Feb; 31(2):919-25. PubMed ID: 24337872
[TBL] [Abstract][Full Text] [Related]
12. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
Song Y; Hou J; Kang L; Gao S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor].
Liu JW; Chen JX; Yu LH; Tian YX; Cui XY; Yan Q; Fu L
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):722-5. PubMed ID: 15733388
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
Zou J; Su H; Zou C; Liang X; Fei Z
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
[TBL] [Abstract][Full Text] [Related]
18. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway.
Min JK; Kim JH; Cho YL; Maeng YS; Lee SJ; Pyun BJ; Kim YM; Park JH; Kwon YG
Biochem Biophys Res Commun; 2006 Oct; 349(3):987-94. PubMed ID: 16962070
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma.
Kim JS; Joo EJ; Chun J; Ha YW; Lee JH; Han Y; Kim YS
Arch Pharm Res; 2012 Mar; 35(4):717-22. PubMed ID: 22553065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]